Close Menu

Back in January, Nina Paynter and her colleagues at Brigham and Women's Hospital and Celera published a study that found that evaluating patients' 9p21.3 polymorphism, which is associated with cardiovascular disease, did not improve cardiovascular disease risk classification when added to an assessment of conventional risk factors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.